wogonin and Lymphoma--T-Cell--Cutaneous

wogonin has been researched along with Lymphoma--T-Cell--Cutaneous* in 1 studies

Other Studies

1 other study(ies) available for wogonin and Lymphoma--T-Cell--Cutaneous

Article	Year
LW-213 induces cell apoptosis in human cutaneous T-cell lymphomas by activating PERK-eIF2α-ATF4-CHOP axis. Acta pharmacologica Sinica, 2021, Volume: 42, Issue:2 Topics: Activating Transcription Factor 4; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; eIF-2 Kinase; Eukaryotic Initiation Factor-2; Female; Flavanones; Humans; Inhibitory Concentration 50; Lymphoma, T-Cell, Cutaneous; Mice; Mice, Inbred NOD; Mice, SCID; Reactive Oxygen Species; Skin Neoplasms; Transcription Factor CHOP; Xenograft Model Antitumor Assays	2021

Article

Year

LW-213 induces cell apoptosis in human cutaneous T-cell lymphomas by activating PERK-eIF2α-ATF4-CHOP axis.

Acta pharmacologica Sinica, 2021, Volume: 42, Issue:2

Topics: Activating Transcription Factor 4; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; eIF-2 Kinase; Eukaryotic Initiation Factor-2; Female; Flavanones; Humans; Inhibitory Concentration 50; Lymphoma, T-Cell, Cutaneous; Mice; Mice, Inbred NOD; Mice, SCID; Reactive Oxygen Species; Skin Neoplasms; Transcription Factor CHOP; Xenograft Model Antitumor Assays

2021